Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
Noosa News20 hours agoGelato Messina and Tony’s Chocolonely Have Collabed on a Super Gooey Bake-At-Home Cookie Pie Perfect for Cold Winter Nights
-
Noosa News20 hours agoProud tradition continues at Cornwalls – Proctor
-
Business24 hours agoAged 30 and earning an average wage? You’re now set up for retirement. Here’s how
-
Business20 hours agoHow to earn $100 a month of passive income from ASX dividends